Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Granulocyte-colony-stimulating factor-producing metaplastic carcinoma of the breast with significant elevation of serum interleukin-17 and vascular endothelial growth factor levels.

Fukui Y, Kawashima M, Kawaguchi K, Takeuchi M, Hirata M, Kataoka TR, Sakurai T, Kataoka M, Kanao S, Nakamoto Y, Hirata K, Yoshimura M, Yoshikawa K, Ishiguro H, Toi M.

Int Cancer Conf J. 2018 Jun 1;7(3):107-113. doi: 10.1007/s13691-018-0330-5. eCollection 2018 Jul.

2.

Murine neonatal skin mast cells are phenotypically immature and minimally sensitized with transplacentally transferred IgE.

Honda Y, Ono S, Honda T, Kataoka TR, Egawa G, Kitoh A, Otsuka A, Nakajima S, Nomura T, Dainichi T, Kabashima K.

J Allergy Clin Immunol. 2019 May 21. pii: S0091-6749(19)30629-3. doi: 10.1016/j.jaci.2019.05.011. [Epub ahead of print] No abstract available.

PMID:
31125593
3.

Immunohistochemical analysis of class-switched subtype of primary cutaneous marginal zone lymphoma in terms of inducible skin-associated lymphoid tissue.

Kogame T, Takegami T, Sakai TR, Kataoka TR, Hirata M, Budair FM, Ueshima C, Matsui M, Nomura T, Kabashima K.

J Eur Acad Dermatol Venereol. 2019 May 24. doi: 10.1111/jdv.15703. [Epub ahead of print] No abstract available.

PMID:
31124191
4.

DIHS/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab.

Takimoto R, Honda T, Kataoka TR, Ueshima C, Otsuka A, Kabashima K.

Eur J Dermatol. 2019 Apr 1;29(2):228-229. doi: 10.1684/ejd.2019.3522. No abstract available.

PMID:
30973334
5.

Alteration of specific cytokine expression patterns in patients with breast cancer.

Kawaguchi K, Sakurai M, Yamamoto Y, Suzuki E, Tsuda M, Kataoka TR, Hirata M, Nishie M, Nojiri T, Kumazoe M, Saito K, Toi M.

Sci Rep. 2019 Feb 27;9(1):2924. doi: 10.1038/s41598-019-39476-9.

6.

Histopathological characterization of the neuroglial tissue in ovarian teratoma associated with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis.

Iemura Y, Yamada Y, Hirata M, Kataoka TR, Minamiguchi S, Haga H.

Pathol Int. 2018 Dec;68(12):677-684. doi: 10.1111/pin.12732. Epub 2018 Nov 14.

PMID:
30427104
7.

Analysis of possible structures of inducible skin-associated lymphoid tissue in lupus erythematosus profundus.

Kogame T, Yamashita R, Hirata M, Kataoka TR, Kamido H, Ueshima C, Matsui M, Nomura T, Kabashima K.

J Dermatol. 2018 Sep;45(9):1117-1121. doi: 10.1111/1346-8138.14498. Epub 2018 Jun 13.

PMID:
29897143
8.

Presence of SCF/CXCL12 double-positive large blast-like cells at the site of cutaneous extramedullary haematopoiesis.

Kogame T, Hirata M, Kataoka TR, Seidel JA, Ueshima C, Matsui M, Nomura T, Kabashima K.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12):e465-e466. doi: 10.1111/jdv.15068. Epub 2018 May 29. No abstract available.

PMID:
29761855
9.

RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells.

Mitsuda Y, Morita K, Kashiwazaki G, Taniguchi J, Bando T, Obara M, Hirata M, Kataoka TR, Muto M, Kaneda Y, Nakahata T, Liu PP, Adachi S, Sugiyama H, Kamikubo Y.

Sci Rep. 2018 Apr 23;8(1):6423. doi: 10.1038/s41598-018-24969-w.

10.

Possible Involvement of Human Mast Cells in the Establishment of Pregnancy via Killer Cell Ig-Like Receptor 2DL4.

Ueshima C, Kataoka TR, Hirata M, Sugimoto A, Iemura Y, Minamiguchi S, Nomura T, Haga H.

Am J Pathol. 2018 Jun;188(6):1497-1508. doi: 10.1016/j.ajpath.2018.02.012. Epub 2018 Mar 22.

PMID:
29577936
11.

Mast Cells Exhibiting Strong Cytoplasmic Staining for IgE and High Affinity IgE Receptor are Increased in IgG4-Related Disease.

Nishida K, Gion Y, Takeuchi M, Tanaka T, Kataoka TR, Yoshino T, Sato Y.

Sci Rep. 2018 Mar 15;8(1):4656. doi: 10.1038/s41598-018-23043-9.

12.

RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice.

Morita K, Tokushige C, Maeda S, Kiyose H, Noura M, Iwai A, Yamada M, Kashiwazaki G, Taniguchi J, Bando T, Hirata M, Kataoka TR, Nakahata T, Adachi S, Sugiyama H, Kamikubo Y.

Blood Adv. 2018 Mar 13;2(5):509-515. doi: 10.1182/bloodadvances.2017009324.

13.

SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis.

Sugimoto A, Kataoka TR, Ueshima C, Takei Y, Kitamura K, Hirata M, Nomura T, Haga H.

Exp Dermatol. 2018 Jun;27(6):641-646. doi: 10.1111/exd.13523.

PMID:
29498772
14.

Total cell necrosis of metastatic malignant melanoma at the regional lymph node in a patient treatment with nivolumab.

Komori T, Otsuka A, Kaku Y, Irie H, Honda T, Hirata M, Kataoka TR, Kabashima K.

J Dermatol. 2018 Jan;45(1):e11-e12. doi: 10.1111/1346-8138.14040. Epub 2017 Sep 25. No abstract available.

PMID:
28944586
15.

Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.

Takei Y, Ueshima C, Kataoka TR, Hirata M, Sugimoto A, Rokutan-Kurata M, Moriyoshi K, Ono K, Murakami I, Iwamoto S, Haga H.

Oncotarget. 2017 Jun 6;8(23):36964-36972. doi: 10.18632/oncotarget.16936.

16.

Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity.

Kawaguchi K, Suzuki E, Nishie M, Kii I, Kataoka TR, Hirata M, Inoue M, Pu F, Iwaisako K, Tsuda M, Yamaguchi A, Haga H, Hagiwara M, Toi M.

Cancer Immunol Immunother. 2017 Sep;66(9):1131-1142. doi: 10.1007/s00262-017-2002-2. Epub 2017 Apr 21.

PMID:
28432397
17.

Maculopapular rash during a nadir period in a patient with acute myeloid leukaemia.

Komori T, Kogame T, Nomura T, Kaku Y, Endo Y, Ueshima C, Hirata M, Kataoka TR, Kawabata H, Kabashima K.

Eur J Dermatol. 2017 Jun 1;27(3):316-317. doi: 10.1684/ejd.2017.2991. No abstract available.

PMID:
28414194
18.

CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.

Ueshima C, Kataoka TR, Takei Y, Hirata M, Sugimoto A, Hirokawa M, Okayama Y, Blumberg RS, Haga H.

Cancer Med. 2017 Apr;6(4):845-856. doi: 10.1002/cam4.1050. Epub 2017 Mar 23.

19.

Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.

Honda Y, Otsuka A, Ono S, Yamamoto Y, Seidel JA, Morita S, Hirata M, Kataoka TR, Takenouchi T, Fujii K, Kanekura T, Okubo Y, Takahashi K, Yanagi T, Hoshina D, Hata H, Abe R, Fujimura T, Funakoshi T, Yoshino K, Masuzawa M, Amoh Y, Tanaka R, Fujisawa Y, Honda T, Kabashima K.

Oncoimmunology. 2016 Nov 4;6(1):e1253657. doi: 10.1080/2162402X.2016.1253657. eCollection 2017.

20.

Perivascular epithelioid cell tumor of the descending colon mimicking a gastrointestinal stromal tumor: a case report.

Iwamoto R, Kataoka TR, Furuhata A, Ono K, Hirota S, Kawada K, Sakai Y, Haga H.

World J Surg Oncol. 2016 Nov 14;14(1):285.

21.

Clinical, Morphologic, and Pathologic Features Associated With Increased FDG Uptake in Schwannoma.

Miyake KK, Nakamoto Y, Kataoka TR, Ueshima C, Higashi T, Terashima T, Nakatani K, Saga T, Minami S, Togashi K.

AJR Am J Roentgenol. 2016 Dec;207(6):1288-1296. Epub 2016 Sep 22.

PMID:
27657364
22.

Adult-onset asthma and periocular xanthogranuloma associated with IgG4-related disease with infiltration of regulatory T cells.

Honda Y, Nakamizo S, Dainichi T, Sasai R, Mimori T, Hirata M, Kataoka TR, Murata Y, Otsuka A, Kabashima K.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e124-e125. doi: 10.1111/jdv.13873. Epub 2016 Aug 13. No abstract available.

PMID:
27519554
23.

Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency.

Yamaguchi M, Kataoka TR, Shibayama T, Fukuda A, Nakazawa A, Minamiguchi S, Sakurai T, Miyagawa-Hayashino A, Yorifuji T, Kasahara M, Uemoto S, Haga H.

Pathol Int. 2016 Jun;66(6):333-6. doi: 10.1111/pin.12414. Epub 2016 May 5.

PMID:
27150549
24.

Variegated RHOA mutations in adult T-cell leukemia/lymphoma.

Nagata Y, Kontani K, Enami T, Kataoka K, Ishii R, Totoki Y, Kataoka TR, Hirata M, Aoki K, Nakano K, Kitanaka A, Sakata-Yanagimoto M, Egami S, Shiraishi Y, Chiba K, Tanaka H, Shiozawa Y, Yoshizato T, Suzuki H, Kon A, Yoshida K, Sato Y, Sato-Otsubo A, Sanada M, Munakata W, Nakamura H, Hama N, Miyano S, Nureki O, Shibata T, Haga H, Shimoda K, Katada T, Chiba S, Watanabe T, Ogawa S.

Blood. 2016 Feb 4;127(5):596-604. doi: 10.1182/blood-2015-06-644948. Epub 2015 Nov 16.

25.

A Case of Noonan Syndrome with Multiple Subcutaneous Tumours with MAPK-ERK/p38 Activation.

Honda T, Kataoka TR, Ueshima C, Miyachi Y, Kabashima K.

Acta Derm Venereol. 2016 Jan;96(1):130-1. doi: 10.2340/00015555-2189. No abstract available.

26.

Screening of BCOR-CCNB3 sarcoma using immunohistochemistry for CCNB3: A clinicopathological report of three pediatric cases.

Shibayama T, Okamoto T, Nakashima Y, Kato T, Sakurai T, Minamiguchi S, Kataoka TR, Shibuya S, Yoshizawa A, Toguchida J, Haga H.

Pathol Int. 2015 Aug;65(8):410-4. doi: 10.1111/pin.12319. Epub 2015 Jun 3.

PMID:
26037154
27.

NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosa.

Ueshima C, Kataoka TR, Hirata M, Koyanagi I, Honda T, Tsuruyama T, Okayama Y, Seiyama A, Haga H.

Exp Dermatol. 2015 Sep;24(9):675-9. doi: 10.1111/exd.12741. Epub 2015 May 26.

PMID:
25940096
28.

The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.

Ueshima C, Kataoka TR, Hirata M, Furuhata A, Suzuki E, Toi M, Tsuruyama T, Okayama Y, Haga H.

Cancer Immunol Res. 2015 Aug;3(8):871-80. doi: 10.1158/2326-6066.CIR-14-0199. Epub 2015 Mar 3.

29.
30.

Stevens-Johnson Syndrome Associated with Mogamulizumab-induced Deficiency of Regulatory T cells in an Adult T-cell Leukaemia Patient.

Honda T, Hishizawa M, Kataoka TR, Ohmori K, Takaori-Kondo A, Miyachi Y, Kabashima K.

Acta Derm Venereol. 2015 May;95(5):606-7. doi: 10.2340/00015555-2027. No abstract available.

31.

CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.

Kataoka TR, Kumanogoh A, Fukuishi N, Ueshima C, Hirata M, Moriyoshi K, Tsuruyama T, Haga H.

Int Immunol. 2015 Feb;27(2):95-103. doi: 10.1093/intimm/dxu087. Epub 2014 Sep 19.

PMID:
25239131
32.

An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.

Kataoka TR, Yamashita N, Furuhata A, Hirata M, Ishida T, Nakamura I, Hirota S, Haga H, Katsuyama E.

World J Surg Oncol. 2014 Jun 18;12:186. doi: 10.1186/1477-7819-12-186.

33.

DIHS/DRESS with remarkable eosinophilic pneumonia caused by zonisamide.

Shibuya R, Tanizaki H, Nakajima S, Koyanagi I, Kataoka TR, Miyachi Y, Kabashima K.

Acta Derm Venereol. 2015 Feb;95(2):229-30. doi: 10.2340/00015555-1863. No abstract available.

34.

Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma.

Onishi N, Kanao S, Kataoka M, Iima M, Sakaguchi R, Kawai M, Kataoka TR, Mikami Y, Toi M, Togashi K.

J Magn Reson Imaging. 2015 Mar;41(3):610-5. doi: 10.1002/jmri.24615. Epub 2014 Mar 4.

35.

Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells.

Ono S, Tanizaki H, Otsuka A, Endo Y, Koyanagi I, Kataoka TR, Miyachi Y, Kabashima K.

Acta Derm Venereol. 2014 May;94(3):329-30. doi: 10.2340/00015555-1713. No abstract available.

36.

Serum granulysin as a possible key marker of the activity of alopecia areata.

Ono S, Otsuka A, Yamamoto Y, Kataoka TR, Koyanagi I, Miyachi Y, Kabashima K.

J Dermatol Sci. 2014 Jan;73(1):74-9. doi: 10.1016/j.jdermsci.2013.08.009. Epub 2013 Sep 2.

PMID:
24035442
37.

CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1.

Kataoka TR, Kumanogoh A, Hirata M, Moriyoshi K, Ueshima C, Kawahara M, Tsuruyama T, Haga H.

Sci Rep. 2013 Oct 4;3:2861. doi: 10.1038/srep02861.

38.

PD-1 regulates the growth of human mastocytosis cells.

Kataoka TR, Fujimoto M, Moriyoshi K, Koyanagi I, Ueshima C, Kono F, Tsuruyama T, Okayama Y, Ra C, Haga H.

Allergol Int. 2013 Mar;62(1):99-104. doi: 10.2332/allergolint.12-OA-0450. Epub 2012 Dec 25.

39.

Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model.

Ohtsubo-Yoshioka M, Nunomura S, Kataoka TR, Okayama Y, Ra C.

Mod Rheumatol. 2013 Jul;23(4):804-10. doi: 10.1007/s10165-012-0749-z. Epub 2012 Oct 6.

PMID:
23053716
40.

Identification of semaphorin 4B as a negative regulator of basophil-mediated immune responses.

Nakagawa Y, Takamatsu H, Okuno T, Kang S, Nojima S, Kimura T, Kataoka TR, Ikawa M, Toyofuku T, Katayama I, Kumanogoh A.

J Immunol. 2011 Mar 1;186(5):2881-8. doi: 10.4049/jimmunol.1003485. Epub 2011 Jan 26.

41.

Adenocarcinomas associated with perianal fistulae in Crohn's disease have a rectal, not an anal, immunophenotype.

Nishigami T, Kataoka TR, Ikeuchi H, Torii I, Sato A, Tomita N, Tsujimura T.

Pathology. 2011 Jan;43(1):36-9. doi: 10.1097/PAT.0b013e328340e4d6.

PMID:
21240063
42.

CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma.

Uwa N, Kataoka TR, Torii I, Sato A, Nishigami T, Song M, Daimon T, Saeki N, Sagawa K, Mouri T, Terada T, Sakagami M, Tsujimura T.

Acta Otolaryngol. 2011 Mar;131(3):323-9. doi: 10.3109/00016489.2010.528792. Epub 2010 Dec 10.

PMID:
21142741
43.

Concomitant adenocarcinoma and colonic non-Hodgkin's lymphoma in a patient with ulcerative colitis: a case report and molecular analysis.

Nishigami T, Kataoka TR, Torii I, Sato A, Tamura K, Hirano H, Hida N, Ikeuchi H, Tsujimura T.

Pathol Res Pract. 2010 Dec 15;206(12):846-50. doi: 10.1016/j.prp.2010.07.007. Epub 2010 Sep 16.

PMID:
20846793
44.

Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium.

Sato A, Torii I, Okamura Y, Yamamoto T, Nishigami T, Kataoka TR, Song M, Hasegawa S, Nakano T, Kamei T, Tsujimura T.

Mod Pathol. 2010 Nov;23(11):1458-66. doi: 10.1038/modpathol.2010.134. Epub 2010 Jul 23.

45.

CD72 negatively regulates KIT-mediated responses in human mast cells.

Kataoka TR, Kumanogoh A, Bandara G, Metcalfe DD, Gilfillan AM.

J Immunol. 2010 Mar 1;184(5):2468-75. doi: 10.4049/jimmunol.0902450. Epub 2010 Jan 25.

46.

Comparison between colorectal low- and high-grade mucinous adenocarcinoma with MUC1 and MUC5AC.

Onodera M, Nishigami T, Torii I, Sato A, Tao LH, Kataoka TR, Yoshikawa R, Tsujimura T.

World J Gastrointest Oncol. 2009 Oct 15;1(1):69-73. doi: 10.4251/wjgo.v1.i1.69.

47.

Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay.

Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, Ueda S, Mano M, Masuda N, Takeda M, Tsujimoto M, Yoshidome K, Inaji H, Nakajima H, Komoike Y, Kataoka TR, Nakamura S, Suzuki K, Tsugawa K, Wakasa K, Okino T, Kato Y, Noguchi S, Matsuura N.

Clin Cancer Res. 2009 Apr 15;15(8):2879-84. doi: 10.1158/1078-0432.CCR-08-1881. Epub 2009 Apr 7.

48.

Heterologous carcinosarcoma of Douglas' pouch with adenocarcinomas of the fallopian tube and the peritoneal cavity.

Kataoka TR, Shinoda H, Yanagawa M, Kamiura S, Nishizawa Y, Hongyo T.

Pathology. 2008 Oct;40(6):641-5. doi: 10.1080/00313020802320721. No abstract available.

PMID:
18752138
49.

Adiponectin plays a protective role in caerulein-induced acute pancreatitis in mice fed a high-fat diet.

Araki H, Nishihara T, Matsuda M, Fukuhara A, Kihara S, Funahashi T, Kataoka TR, Kamada Y, Kiyohara T, Tamura S, Hayashi N, Shimomura I.

Gut. 2008 Oct;57(10):1431-40. doi: 10.1136/gut.2007.135665. Epub 2008 Jun 25.

PMID:
18579666
50.

Stat4 suppresses the proliferation of connective tissue-type mast cells.

Kataoka TR, Nishizawa Y.

Lab Invest. 2008 Aug;88(8):856-64. doi: 10.1038/labinvest.2008.51. Epub 2008 Jun 2.

Supplemental Content

Loading ...
Support Center